It is estimated that over 300 million people in the world are impacted by rare diseases. In a recent study it was estimated that rare...

Antisense Therapeutics Limited (ASX: ANP; FSE: AWY) Antisense is an Australian publicly listed biotechnology company (with German...

European investors have shown strong interest in Antisense Therapeutics Limited (ASX: ANP: FWB: AWY) since the company was dual listed in...

Platform technology Using mRNA as a medicine is a radically different approach than treating disease with other drug classes. mRNA is the...

Antisense Therapeutics (ASX: ANP) and (FRA: AWY) are up over 60% in 2 months. 2 major reasons for this: Sarpeta Therapeutics announced...

As the 2020 year of biotech investing draws to a close, mRNA technology stands out as the defining technology of the decade. Never before...

2020 was the first year that investment in ESG-oriented funds hit the USD 1 trillion figure (according to FT Advisor). However, Morgan...

Australian based innovative biotech company, Antisense Therapeutics Limited (ASX: ANP) and (FRA: AWY) received a strong brokers...

RNA is the target that forms the basis of Ionis's Pharmaceuticals (FRA: ISI) and (NASDAQ: IONS) novel drug discovery platform, The...

The recent news that BioNTech and Pfizer’s Covid-19 vaccine was more than 90 per cent effective in clinical trials has increased...

Australia has ranked in the top five globally for biotechnology three years running, outperforming nations such as the United Kingdom and...